Switch to:

Biomarin Pharmaceutical Shiller PE Ratio

: (As of Today)
View and export this data going back to 1999. Start your Free Trial

As of today (2019-12-09), Biomarin Pharmaceutical's current share price is $79.97. Biomarin Pharmaceutical's E10 for the quarter that ended in Sep. 2019 was $-1.59. Biomarin Pharmaceutical's Shiller PE Ratio for today is .

During the past years, Biomarin Pharmaceutical's highest Shiller PE Ratio was 6547.00. The lowest was 0.00. And the median was 368.20.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biomarin Pharmaceutical's adjusted earnings per share data for the three months ended in Sep. 2019 was $0.300. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $-1.59 for the trailing ten years ended in Sep. 2019.


Biomarin Pharmaceutical Shiller PE Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Biomarin Pharmaceutical Shiller PE Ratio Distribution

* The bar in red indicates where Biomarin Pharmaceutical's Shiller PE Ratio falls into.



Biomarin Pharmaceutical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biomarin Pharmaceutical's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=79.97/-1.59
=

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical's E10 for the quarter that ended in Sep. 2019 is calculated as:

For example, Biomarin Pharmaceutical's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=0.3/256.358*256.358
=0.300

Current CPI (Sep. 2019) = 256.358.

Biomarin Pharmaceutical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200912 0.050 215.949 0.059
201003 0.010 217.631 0.012
201006 -0.010 217.965 -0.012
201009 1.680 218.439 1.972
201012 -0.140 219.179 -0.164
201103 -0.040 223.467 -0.046
201106 -0.050 225.722 -0.057
201109 -0.160 226.889 -0.181
201112 -0.240 225.672 -0.273
201203 -0.210 229.392 -0.235
201206 -0.270 229.478 -0.302
201209 -0.040 231.407 -0.044
201212 -0.430 229.601 -0.480
201303 -0.310 232.773 -0.341
201306 -0.160 233.504 -0.176
201309 -0.380 234.149 -0.416
201312 -0.440 233.049 -0.484
201403 -0.270 236.293 -0.293
201406 -0.230 238.343 -0.247
201409 0.050 238.031 0.054
201412 -0.470 234.812 -0.513
201503 -0.430 236.119 -0.467
201506 -0.510 238.638 -0.548
201509 -0.600 237.945 -0.646
201512 0.390 236.525 0.423
201603 -0.510 238.132 -0.549
201606 -2.580 241.018 -2.744
201609 -0.220 241.428 -0.234
201612 -0.530 241.432 -0.563
201703 -0.090 243.801 -0.095
201706 -0.210 244.955 -0.220
201709 -0.070 246.819 -0.073
201712 -0.300 246.524 -0.312
201803 -0.260 249.554 -0.267
201806 -0.090 251.989 -0.092
201809 -7.000 252.439 -7.109
201812 -0.030 251.233 -0.031
201903 -0.320 254.202 -0.323
201906 -0.210 256.143 -0.210
201909 0.300 256.358 0.300

Add all the adjusted EPS together and divide 10 will get our E10.


Biomarin Pharmaceutical  (NAS:BMRN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biomarin Pharmaceutical Shiller PE Ratio Related Terms


Biomarin Pharmaceutical Shiller PE Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)